REC Interventional Cardiology最新文献

筛选
英文 中文
An interview with Bruno Scheller. 布鲁诺·谢勒的采访。
IF 1.5
REC Interventional Cardiology Pub Date : 2026-01-24 eCollection Date: 2026-04-01 DOI: 10.24875/RECICE.M26000565
Fernando Alfonso
{"title":"An interview with Bruno Scheller.","authors":"Fernando Alfonso","doi":"10.24875/RECICE.M26000565","DOIUrl":"10.24875/RECICE.M26000565","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 2","pages":"127-129"},"PeriodicalIF":1.5,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design of the LUDICO study: effectiveness and safety of coronary laser in undilatable or uncrossable lesions. LUDICO研究的设计:冠状动脉激光治疗不可扩张或不可跨越病变的有效性和安全性。
IF 1.5
REC Interventional Cardiology Pub Date : 2026-01-22 eCollection Date: 2026-07-01 DOI: 10.24875/RECICE.M25000560
Alfonso Jurado-Román, Jon Zubiaur, Mattia Basile, Guillermo Galeote, Santiago Jiménez-Valero, Javier Suárez de Lezo, Francisco Hidalgo, Ignacio Gallo, Ana Belén Cid-Álvarez, Neus Bellera, Bruno García Del Blanco, Borja Rivero Santana, Daniel Tebar, Ariana Gonzálvez, Raúl Moreno
{"title":"Design of the LUDICO study: effectiveness and safety of coronary laser in undilatable or uncrossable lesions.","authors":"Alfonso Jurado-Román, Jon Zubiaur, Mattia Basile, Guillermo Galeote, Santiago Jiménez-Valero, Javier Suárez de Lezo, Francisco Hidalgo, Ignacio Gallo, Ana Belén Cid-Álvarez, Neus Bellera, Bruno García Del Blanco, Borja Rivero Santana, Daniel Tebar, Ariana Gonzálvez, Raúl Moreno","doi":"10.24875/RECICE.M25000560","DOIUrl":"10.24875/RECICE.M25000560","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Excimer laser coronary atherectomy (ELCA) is increasingly used in complex percutaneous coronary interventions (PCI), particularly in cases of \"balloon failure,\" which includes both uncrossable and undilatable coronary artery lesions. Although these 2 scenarios represent distinct technical and clinical challenges, they are usually evaluated using the same safety and efficacy endpoints. As a result, there is a lack of specific evidence on the safety and efficacy profile of ELCA in each of these situations. Furthermore, the role of intracoronary imaging in optimizing ELCA use remains insufficiently defined.</p><p><strong>Methods: </strong>This will be an investigator-initiated, multicenter, single-arm, open-label, prospective observational study. Patients with an indication for PCI and undilatable (non-compliant balloon dilatation < 80% at burst pressure) or uncrossable (uncrossable with a \"small-profile balloon\" with adequate support, left to the operator's discretion) coronary artery lesions treated with ELCA will be included. Intravascular imaging will be highly advised and analyzed in a core laboratory. Device success, angiographical success, procedural success, clinical success and related complications will be evaluated. Patients will be postoperatively followed for 1 year and clinical events will be recorded.</p><p><strong>Conclusions: </strong>The LUDICO study will be a multicentre, prospective study of ELCA therapy in uncrossable or undilatable coronary lesions. The study aims to evaluate the safety and efficacy profile of ELCA in these lesions as well as the clinical results at the 1 year follow-up in this setting. (ClinicalTrials.gov: NCT07206082).</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"152-160"},"PeriodicalIF":1.5,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical utility of thrombus aspiration using the Hunter catheter in patients with acute myocardial infarction: the Hunted registry. 亨特导管在急性心肌梗死患者血栓抽吸中的临床应用:亨特登记。
IF 1.5
REC Interventional Cardiology Pub Date : 2026-01-22 eCollection Date: 2026-07-01 DOI: 10.24875/RECICE.M25000556
Darío G Borraz-Noriega, Joan F Andrés-Cordón, Elena Cañedo, Fernando Panchano-Castro, Edgar Fadeuilhe, Michele Trichilo, Victoria Vilalta, Eduard Fernández-Nofrerias, Oriol Rodríguez-Leor, Irene Santos-Pardo, Xavier Carrillo
{"title":"Clinical utility of thrombus aspiration using the Hunter catheter in patients with acute myocardial infarction: the Hunted registry.","authors":"Darío G Borraz-Noriega, Joan F Andrés-Cordón, Elena Cañedo, Fernando Panchano-Castro, Edgar Fadeuilhe, Michele Trichilo, Victoria Vilalta, Eduard Fernández-Nofrerias, Oriol Rodríguez-Leor, Irene Santos-Pardo, Xavier Carrillo","doi":"10.24875/RECICE.M25000556","DOIUrl":"10.24875/RECICE.M25000556","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Manual thrombectomy (MT) during primary percutaneous coronary intervention (PCI) aims to reduce thrombus burden. Our study evaluates the outcomes and predictors of successful MT.</p><p><strong>Methods: </strong>The Hunted registry is a retrospective, single-center cohort study including patients who underwent MT during PCI using the Hunter catheter from July 2020 through February 2022. MT success was defined as an angiographic reduction to a Thrombolysis in Myocardial Infarction (TIMI) thrombus grade of ≤ 2, with clinical follow-up for major adverse cardiovascular events.</p><p><strong>Results: </strong>Among 750 patients with acute myocardial infarction who underwent PCI, 401 (53%) received MT. The mean age of treated patients was 62 years (80% men). MT was effective in 327 patients (81.55%). Predictors of successful MT included larger vessel diameter (P < .001), high thrombus burden (TIMI grade ≥ 4 flow; P < .001), and non-circumflex target vessels (P < .001). Device-related complications occurred in 17 patients (4.3%). At follow-up, major adverse events occurred in 8.98% of patients at 1 year and in 9.97% at 2 years.</p><p><strong>Conclusions: </strong>In patients with ST-segment elevation myocardial infarction undergoing PCI, MT with the Hunter catheter in selected cases with high thrombus burden (TIMI grade ≥ 4 flow), non-circumflex target vessels, and vessel diameters > 2.5 mm, is a safe and effective technique with a low rate of complications.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"161-167"},"PeriodicalIF":1.5,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Out-of-hours presentation and 30-day myocardial infarction mortality in Mexico: a 2014-2023 retrospective study. 墨西哥非工作时间表现和30天心肌梗死死亡率:2014-2023年回顾性研究
IF 1.5
REC Interventional Cardiology Pub Date : 2026-01-20 eCollection Date: 2026-07-01 DOI: 10.24875/RECICE.M25000559
Diego Arriaga-Izabal, Francisco Morales-Lazcano, Adrián Canizalez-Román
{"title":"Out-of-hours presentation and 30-day myocardial infarction mortality in Mexico: a 2014-2023 retrospective study.","authors":"Diego Arriaga-Izabal, Francisco Morales-Lazcano, Adrián Canizalez-Román","doi":"10.24875/RECICE.M25000559","DOIUrl":"10.24875/RECICE.M25000559","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Although acute myocardial infarction (AMI) remains a leading cause of death in Mexico, the impact of out-of-hours presentation on mortality remains understudied. The aim of this study was to evaluate the association between out-of-hours admissions (nights, weekends, holidays) and 30-day mortality in patients with AMI in Mexican hospitals, with a focus on the role of catheterization laboratories (cath lab).</p><p><strong>Methods: </strong>We conducted a retrospective cohort study to analyze emergency admissions from December 2014 through August 2023. Admissions were classified as out-of-hours or during-hours and were stratified by hospital type (with or without cath lab). Cox regression models adjusted for sociodemographic, health, and temporal variables were used to analyze mortality risks.</p><p><strong>Results: </strong>The study included a total of 29 131 cases: 4515 in percutaneous coronary intervention (PCI)-capable centers (group 1) and 24 616 in non-PCI-capable centers (group 2). Admissions outside regular hours accounted for 46.7% in group 1 and 53.6% in group 2. Adjusted analysis showed that although the presence of a cath lab was protective (HR, 0.25; 95%CI, 0.23-0.28), admissions outside regular hours increased the risk of mortality in both groups (group 1: HR, 1.25; 95%CI, 1.04-1.50; group 2: HR, 1.16; 95%CI, 1.11-1.22). Although overnight shifts increased the risk of death in both groups, weekends and holidays increased such risk only in non-PCI-capable centers.</p><p><strong>Conclusions: </strong>Out-of-hours admissions were associated with higher mortality, and unlike in developed countries, the presence of a cath lab did not improve out-of-hours outcomes.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"177-183"},"PeriodicalIF":1.5,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Device console programming in patients undergoing TAVI with preexisting cardiac implantable electronic devices: a practical guide. 设备控制台编程患者接受TAVI与先前存在的心脏植入式电子设备:实用指南。
IF 1.5
REC Interventional Cardiology Pub Date : 2026-01-20 eCollection Date: 2026-07-01 DOI: 10.24875/RECICE.M25000561
Filippo Pensotti, Luis Jorge Garnacho, Mario García-Gómez, Akash Jain, Marcelo Rodríguez, Mauricio Zuñiga, María Sandín-Fuentes, Alberto Campo, Carlos Cortés-Villar, Sara Blasco, Luis Llamas-Fernández, Sofía Campillo, J Alberto San Román, Ignacio J Amat-Santos
{"title":"Device console programming in patients undergoing TAVI with preexisting cardiac implantable electronic devices: a practical guide.","authors":"Filippo Pensotti, Luis Jorge Garnacho, Mario García-Gómez, Akash Jain, Marcelo Rodríguez, Mauricio Zuñiga, María Sandín-Fuentes, Alberto Campo, Carlos Cortés-Villar, Sara Blasco, Luis Llamas-Fernández, Sofía Campillo, J Alberto San Román, Ignacio J Amat-Santos","doi":"10.24875/RECICE.M25000561","DOIUrl":"10.24875/RECICE.M25000561","url":null,"abstract":"<p><p>Transcatheter aortic valve implantation (TAVI) is established as the standard of care for patients across all surgical risk profiles, with expanding indications in younger and lower-risk populations. A substantial proportion of patients eligible for TAVI have preexisting cardiac implantable electronic devices (CIED). Temporary transvenous right ventricular (RV) pacing is routinely used during TAVI to facilitate procedural safety but carries inherent risks, including RV perforation, cardiac tamponade, and lead dislodgement. Alternative pacing strategies, such as left ventricular pacing via the valve delivery guidewire, have been proposed to reduce procedural complications. In patients with a preexisting CIED, leveraging the implanted device for procedural pacing represents a rational and potentially safer option. However, its adoption remains limited, largely due to unfamiliarity with device-specific programming. This article provides a detailed, step-by-step practical guide for programming rapid ventricular pacing using the most widely encountered CIED platforms: Biotronik, Medtronic, Abbott/St. Jude, Sorin, and Boston Scientific. The specific programming pathways for each manufacturer are summarized to facilitate safe, effective, and reproducible implementation during TAVI.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"184-189"},"PeriodicalIF":1.5,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter treatment of aortic coarctation. 经导管治疗主动脉缩窄。
IF 1.5
REC Interventional Cardiology Pub Date : 2026-01-19 eCollection Date: 2026-04-01 DOI: 10.24875/RECICE.M25000557
Victor Arévalos, Anthony Salazar-Rodríguez, Guillermo Velázquez, Javier Galeano, Osmar Antonio Centurión, Andrea Ruberti, Raquel Luna-López, Igor Morr-Verenzuela, Pedro Cepas-Guillén, Sílvia Montserrat, Susanna Prat-González, Bárbara Vidal, Laura Sanchis, Íñigo Anduaga, Alejandro Fernández-Cisneros, Daniel Pereda, Ricardo Sanz-Ruiz, Juan M Carretero Bellón, Ander Regueiro, Omar Abdul-Jawad Altisent, Salvatore Brugaletta, Manel Sabaté, Eduardo Flores-Umanzor, Xavier Freixa
{"title":"Transcatheter treatment of aortic coarctation.","authors":"Victor Arévalos, Anthony Salazar-Rodríguez, Guillermo Velázquez, Javier Galeano, Osmar Antonio Centurión, Andrea Ruberti, Raquel Luna-López, Igor Morr-Verenzuela, Pedro Cepas-Guillén, Sílvia Montserrat, Susanna Prat-González, Bárbara Vidal, Laura Sanchis, Íñigo Anduaga, Alejandro Fernández-Cisneros, Daniel Pereda, Ricardo Sanz-Ruiz, Juan M Carretero Bellón, Ander Regueiro, Omar Abdul-Jawad Altisent, Salvatore Brugaletta, Manel Sabaté, Eduardo Flores-Umanzor, Xavier Freixa","doi":"10.24875/RECICE.M25000557","DOIUrl":"10.24875/RECICE.M25000557","url":null,"abstract":"<p><p>Aortic coarctation is a congenital disease that consists of the narrowing of the thoracic aorta, leading to distal blood flow obstruction. Significant aortic coarctation is associated with hypertension and distal hypoperfusion, with a poor prognosis without intervention. Initially, treatment was surgical; however, less invasive techniques such as percutaneous balloon angioplasty later emerged and proved effective in selected patients. The introduction of stent implantation significantly improved the outcomes, making percutaneous repair the preferred option, especially in adolescents and adults. However, immediate and long-term complications persist, which has driven research efforts aimed at improving the safety and efficacy profile. Modern strategies now focus on advanced stent designs, offering better delivery profiles and high redilatation potential. Gaps in knowledge remain, and data from studies with longer follow-up will be essential to further elucidate disease progression in these patients. This review aims to offer a comprehensive overview of these percutaneous procedures, discussing recent advancements, clinical outcomes, and future perspectives.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 2","pages":"107-115"},"PeriodicalIF":1.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148976799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of edge-to-edge mitral valve repair in patients with mitral regurgitation evaluated for heart transplantation. 二尖瓣边缘对边缘修复心脏移植患者二尖瓣反流的疗效评价。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-12-29 eCollection Date: 2026-07-01 DOI: 10.24875/RECICE.M25000554
Flavia Di Cosmo, Lucas Barreiro Mesa, Martín Ruiz Ortiz, Cristina Urbano Sánchez, Manuel Pan Álvarez-Ossorio, Dolores Mesa Rubio
{"title":"Outcomes of edge-to-edge mitral valve repair in patients with mitral regurgitation evaluated for heart transplantation.","authors":"Flavia Di Cosmo, Lucas Barreiro Mesa, Martín Ruiz Ortiz, Cristina Urbano Sánchez, Manuel Pan Álvarez-Ossorio, Dolores Mesa Rubio","doi":"10.24875/RECICE.M25000554","DOIUrl":"10.24875/RECICE.M25000554","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"190-193"},"PeriodicalIF":1.5,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventional management of congenital heart disease: integrating perspectives for a shared future. 先天性心脏病的介入治疗:为共同的未来整合观点。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-12-29 eCollection Date: 2026-04-01 DOI: 10.24875/RECICE.M25000555
Mónica Fernández Quero, Agustín Guisado Rasco, Félix Coserria Sánchez
{"title":"Interventional management of congenital heart disease: integrating perspectives for a shared future.","authors":"Mónica Fernández Quero, Agustín Guisado Rasco, Félix Coserria Sánchez","doi":"10.24875/RECICE.M25000555","DOIUrl":"10.24875/RECICE.M25000555","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 2","pages":"69-71"},"PeriodicalIF":1.5,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Embolization of left atrial appendage occluders: review of the current evidence. 左心耳闭塞器栓塞术:当前证据的回顾。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-12-15 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000547
Miguel Á Martín-Arena, Guillermo Galeote-García, Alejandro Lara-García, Alfonso Jurado-Román, Santiago Jiménez-Valero, Ariana Gonzálvez-García, Daniel Tébar-Márquez, Borja Rivero-Santana, Jon Zubiaur, Mattia Basile, Silvia Valbuena-López, Lucía Fernández-Gassó, Regina Dalmau González-Gallarza, Raúl Moreno
{"title":"Embolization of left atrial appendage occluders: review of the current evidence.","authors":"Miguel Á Martín-Arena, Guillermo Galeote-García, Alejandro Lara-García, Alfonso Jurado-Román, Santiago Jiménez-Valero, Ariana Gonzálvez-García, Daniel Tébar-Márquez, Borja Rivero-Santana, Jon Zubiaur, Mattia Basile, Silvia Valbuena-López, Lucía Fernández-Gassó, Regina Dalmau González-Gallarza, Raúl Moreno","doi":"10.24875/RECICE.M25000547","DOIUrl":"10.24875/RECICE.M25000547","url":null,"abstract":"<p><p>Percutaneous left atrial appendage closure has emerged as a promising procedure for patients with non-valvular atrial fibrillation with a very high or prohibitive bleeding risk. It is a safe technique, with a low rate of complications; however, complications, such as device embolization can be potentially serious, and decision-making as well as selecting the most appropriate strategy may be challenging due to the limited evidence available in this context. This review provides an overview of the most critical aspects of left atrial appendage closure device embolization focusing on its prevalence, management strategies, and treatment options.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 1","pages":"46-54"},"PeriodicalIF":1.5,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How does major bleeding influence decision-making in patients eligible for transfemoral TAVI? A single-center experience. 大出血如何影响经股TAVI患者的决策?单中心体验。
IF 1.5
REC Interventional Cardiology Pub Date : 2025-12-14 eCollection Date: 2026-04-01 DOI: 10.24875/RECICE.M25000548
Carmen Vidau Getán, Domingo López Vázquez, Xacobe Flores Ríos, Borja Souto Caínzos, Fernando Rebollal Leal, Pablo Piñón Esteban, Guillermo Aldama López, Jorge Salgado Fernández, Miguel González Montes, Gabriel González Barbeito, Ramón Calviño Santos, José Manuel Vázquez Rodríguez
{"title":"How does major bleeding influence decision-making in patients eligible for transfemoral TAVI? A single-center experience.","authors":"Carmen Vidau Getán, Domingo López Vázquez, Xacobe Flores Ríos, Borja Souto Caínzos, Fernando Rebollal Leal, Pablo Piñón Esteban, Guillermo Aldama López, Jorge Salgado Fernández, Miguel González Montes, Gabriel González Barbeito, Ramón Calviño Santos, José Manuel Vázquez Rodríguez","doi":"10.24875/RECICE.M25000548","DOIUrl":"10.24875/RECICE.M25000548","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>To evaluate the impact of bleeding on the risk-benefit balance of coronary revascularization prior to transfemoral transcatheter aortic valve implantation (TF-TAVI).</p><p><strong>Methods: </strong>We conducted a retrospective analysis of the patients who underwent TF-TAVI at our center between 2008 and 2018 to evalute the management of coronary artery disease (percutaneous revascularization vs no revascularization). Subsequently, the rate of major bleeding -defined according to the Bleeding Academic Research Consortium (BARC) criteria (type 3-5)- and major adverse cardiovascular events (MACE) was compared between the 2 groups over a mean 60-month follow-up period.</p><p><strong>Results: </strong>A total of 379 patients were included. The overall rate of major bleeding was 21.4%, higher in revascularized patients but without reaching statistical significance. The rate of major bleeding between coronary angiography and TF-TAVI implantation was 5.5% and significantly higher in revascularized patients (12.0% vs 3.5%; P = .07). During the hospitalization for TF-TAVI and throughout follow-up, the rate of major bleeding was 6.1% and 9.6%, respectively, with no significant inter-group differences. There were no significant differences either in the 5-year rate of MACE.</p><p><strong>Conclusions: </strong>In our patient cohort, pre-TF-TAVI preoperative coronary revascularization was associated with an initially higher bleeding risk; however, no statistically significant differences were observed in major bleeding or MACE at the 5-year follow-up. These findings support the need to generate high-quality clinical evidence to demonstrate the net clinical benefit of coronary revascularization in this context.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 2","pages":"79-84"},"PeriodicalIF":1.5,"publicationDate":"2025-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书